ANXA8 Down-regulation by EGF-FOXO4 Signaling Is Involved in Cell Scattering and Tumor Metastasis of Cholangiocarcinoma

Gastroenterology

Volumn 137, Issue 3, 2009, Pages

  Lee, Mi Jin ^a   Yu, Gyung Ran ^a   Yoo, Hee Jung ^a   Kim, Jong Hyun ^a   Yoon, Byung Il ^b   Choi, Yang Kyu ^c   Kim, Dae Ghon ^a  

^a Chonbuk National University Medical School   (South Korea)

^b Kangwon National University   (South Korea)

^c Konkuk University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ANNEXIN; ANNEXIN A8; EPIDERMAL GROWTH FACTOR RECEPTOR; F ACTIN; FOCAL ADHESION KINASE; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; TRANSCRIPTION FACTOR FOXO; TRANSCRIPTION FACTOR FOXO4; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; BILE DUCT CARCINOMA; CELL MIGRATION; CELL STRUCTURE; CONTROLLED STUDY; DOWN REGULATION; GENE EXPRESSION; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; METASTASIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; TUMOR DIFFERENTIATION; TUMOR GROWTH;

EID: 69249129158     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.gastro.2009.04.015     Document Type: Article

References (43)

1. Shimada M., Takenaka K., Rikimaru T., et al. Characteristics of sarcomatous cholangiocarcinoma of the liver. Hepatogastroenterology 47 (2000) 956-961
2. Thiery J.P. Epithelial-mesenchymal transitions in development and pathologies. Curr Opin Cell Biol 15 (2003) 740-746
3. Birchmeier C., Birchmeier W., and Brand-Saberi B. Epithelial-mesenchymal transitions in cancer progression. Acta Anat (Basel) 156 (1996) 217-226
4. Shibamoto S., Hayakawa M., Hori T., et al. Hepatocyte growth factor and transforming growth factor-β stimulate both cell growth and migration of human gastric adenocarcinoma cells. Cell Struct Funct 17 (1992) 185-190
5. Barrandon Y., and Green H. Cell migration is essential for sustained growth of keratinocyte colonies: the roles of transforming growth factor-α and epidermal growth factor. Cell 50 (1987) 1131-1137
6. Blay J., and Brown K.D. Epidermal growth factor promotes the chemotactic migration of cultured rat intestinal epithelial cells. J Cell Physiol 124 (1985) 107-112
7. Beiman M., Shilo B.Z., and Volk T. Heartless, a Drosophila FGF receptor homolog, is essential for cell migration and establishment of several mesodermal lineages. Genes Dev 10 (1996) 2993-3002
8. Reichmann E., Schwarz H., Deiner E.M., et al. Activation of an inducible c-Fos ER fusion protein causes loss of epithelial polarity and triggers epithelial-fibroblastoid cell conversion. Cell 71 (1992) 1103-1116
9. Eger A., Stockinger A., Schaffhauser B., et al. Epithelial mesenchymal transition by c-Fos estrogen receptor activation involves nuclear translocation of β-catenin and up-regulation of β-catenin/lymphoid enhancer binding factor-1 transcriptional activity. J Cell Biol 148 (2000) 173-188
10. Malliri A., Symons M., Hennigan R.F., et al. The transcription factor AP-1 is required for EGF-induced activation of rho-like GTPases, cytoskeletal rearrangements, motility, and in vitro invasion of A431 cells. J Cell Biol 143 (1998) 1087-1099
11. Batlle E., Sancho E., Franci C., et al. The transcription factor snail is a repressor of E-cadherin gene expression in epithelial tumour cells. Nat Cell Biol 2 (2000) 84-89
12. Cano A., Perez-Moreno M.A., Rodrigo I., et al. The transcription factor snail controls epithelial-mesenchymal transitions by repressing E-cadherin expression. Nat Cell Biol 2 (2000) 76-83
13. Ros M.A., Sefton M., and Nieto M.A. Slug, a zinc finger gene previously implicated in the early patterning of the mesoderm and the neural crest, is also involved in chick limb development. Development 124 (1997) 1821-1829
14. Savagner P., Yamada K.M., and Thiery J.P. The zinc-finger protein slug causes desmosome dissociation, an initial and necessary step for growth factor-induced epithelial-mesenchymal transition. J Cell Biol 137 (1997) 1403-1419
15. Yoon J.H., Gwak G.Y., Lee H.S., et al. Enhanced epidermal growth factor receptor activation in human cholangiocarcinoma cells. J Hepatol 41 (2004) 808-814
16. Lo H.W., Hsu S.C., Xia W., et al. Epidermal growth factor receptor cooperates with signal transducer and activator of transcription 3 to induce epithelial-mesenchymal transition in cancer cells via up-regulation of TWIST gene expression. Cancer Res 67 (2007) 9066-9076
17. Ackland M.L., Newgreen D.F., Fridman M., et al. Epidermal growth factor-induced epithelio-mesenchymal transition in human breast carcinoma cells. Lab Invest 83 (2003) 435-448
18. Kim J.H., Liu L., Lee S.O., et al. Susceptibility of cholangiocarcinoma cells to parthenolide-induced apoptosis. Cancer Res 65 (2005) 6312-6320
19. Grubman S.A., Perrone R.D., Lee D.W., et al. Regulation of intracellular pH by immortalized human intrahepatic biliary epithelial cell lines. Am J Physiol 266 (1994) G1060-G1070
20. Diatchenko L., Lau Y.F., Campbell A.P., et al. Suppression subtractive hybridization: a method for generating differentially regulated or tissue-specific cDNA probes and libraries. Proc Natl Acad Sci U S A 93 (1996) 6025-6030
21. Takaishi H., Konishi H., Matsuzaki H., et al. Regulation of nuclear translocation of forkhead transcription factor AFX by protein kinase B. Proc Natl Acad Sci U S A 96 (1999) 11836-11841
22. Itoh K., Yoshioka K., Akedo H., et al. An essential part for Rho-associated kinase in the transcellular invasion of tumor cells. Nat Med 5 (1999) 221-225
23. Nishi H., Isaka K., Sagawa Y., et al. p53 Homologue p63 represses epidermal growth factor receptor expression. J Biol Chem 276 (2001) 41717-41724
24. Golubovskaya V., Kaur A., and Cance W. Cloning and characterization of the promoter region of human focal adhesion kinase gene: nuclear factor-κB and p53 binding sites. Biochim Biophys Acta 1678 (2004) 111-125
25. Yoo H.-J., Yun B.-R., and Kwon J.-H. Genetic and expression alterations in association with the sarcomatous change of cholangiocarcinoma cells. Exp Mol Med 41 (2009) 102-115
26. Pagan R., Martín I., Llobera M., et al. Epithelial-mesenchymal transition of cultured rat neonatal hepatocytes is differentially regulated in response to epidermal growth factor and dimethyl sulfoxide. Hepatology 25 (1997) 598-606
27. Wu X., Suetsugu S., Cooper L.A., et al. Focal adhesion kinase regulation of N-WASP subcellular localization and function. J Biol Chem 279 (2004) 9565-9576
28. Kops G.J., de Ruiter N.D., De Vries-Smits A.M., et al. Direct control of the Forkhead transcription factor AFX by protein kinase B. Nature 398 (1999) 630-634
29. Takaishi H., Konishi H., Matsuzaki H., et al. Regulation of nuclear translocation of forkhead transcription factor AFX by protein kinase B. Proc Natl Acad Sci U S A 96 (1999) 11836-11841
30. Abid M.R., Guo S., Minami T., et al. Vascular endothelial growth factor activates PI3K/Akt/forkhead signaling in endothelial cells. Arterioscler Thromb Vasc Biol 24 (2004) 294-300
31. Gabriel B., zur Hausen A., Stickeler E., et al. Weak expression of focal adhesion kinase (pp125FAK) in patients with cervical cancer is associated with poor disease outcome. Clin Cancer Res 12 (2006) 2476-2483
32. Ghosh Choudhury G., Lenin M., Calhaun C., et al. PDGF inactivates forkhead family transcription factor by activation of Akt in glomerular mesangial cells. Cell Signal 15 (2003) 161-170
33. Mani S.A., Yang J., Brooks M., et al. Mesenchyme Forkhead 1 (FOXC2) plays a key role in metastasis and is associated with aggressive basal-like breast cancers. Proc Natl Acad Sci U S A 104 (2007) 10069-10074
34. Gilmore A.P., and Romer L.H. Inhibition of focal adhesion kinase (FAK) signaling in focal adhesions decreases cell motility and proliferation. Mol Biol Cell 7 (1996) 1209-1224
35. FAK) in invasive human tumors. Cancer Res 55 (1995) 2752-2755
36. Lu Z., Jiang G., Blume-Jensen P., et al. Epidermal growth factor-induced tumor cell invasion and metastasis initiated by dephosphorylation and down-regulation of focal adhesion kinase. Mol Cell Biol 21 (2001) 4016-4031
37. Yu D.H., Qu C.K., Henegariu O., Lu X., et al. Protein-tyrosine phosphatase Shp-2 regulates cell spreading, migration, and focal adhesion. J Biol Chem 273 (1998) 21125-21131
38. Lamouille S., and Derynck R. Cell size and invasion in TGF-β-induced epithelial to mesenchymal transition is regulated by activation of the mTOR pathway. J Cell Biol 178 (2007) 437-451
39. Zhang H., Bajraszewski N., Wu E., et al. PDGFRs are critical for PI3K/Akt activation and negatively regulated by mTOR. J Clin Invest 117 (2007) 730-738
40. Goebeler V., Ruhe D., Gerke V., et al. Annexin A8 displays unique phospholipid and F-actin binding properties. FEBS Lett 580 (2006) 2430-2434
41. Morgillo F., and Lee H.Y. Resistance to epidermal growth factor receptor-targeted therapy. Drug Resist Updat 8 (2005) 298-310
42. Raben D., Helfrich B.A., Chan D., et al. ZD1839, a selective epidermal growth factor receptor tyrosine kinase inhibitor, alone and in combination with radiation and chemotherapy as a new therapeutic strategy in non-small cell lung cancer. Semin Oncol 29 (2002) 37-46
43. Slamon D.J., Leyland-Jones B., Shak S., et al. Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2. N Engl J Med 344 (2001) 783-792